当前位置:
X-MOL 学术
›
Clin. Neurol. Neurosurg.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The Association between thromboxane A2 receptor gene polymorphisms and the risk of cerebral infarction
Clinical Neurology and Neurosurgery ( IF 1.8 ) Pub Date : 2020-11-01 , DOI: 10.1016/j.clineuro.2020.106134 Lina Mei 1 , Zhangguo Shen 2 , Changan Wu 3
Clinical Neurology and Neurosurgery ( IF 1.8 ) Pub Date : 2020-11-01 , DOI: 10.1016/j.clineuro.2020.106134 Lina Mei 1 , Zhangguo Shen 2 , Changan Wu 3
Affiliation
To explore the association between thromboxane A2 receptor (TXA2R) gene polymorphisms and the risk of cerebral infarction. We screened the relevant publications through the search engines in PubMed, Google Scholar, Embase, Web of Science, and China National Knowledge Infrastructure (the latest search update was performed on July 1, 2020). Gene-disease associations were measured using the estimation of OR (95 % CI) based on five genetic inheritance models. Totally three studies were included in this meta-analysis. TXA2R rs768963 polymorphism in homozygote comparison (OR = 1.86, 95 % CI: 1.35-2.56), heterozygote comparison (OR = 1.81, 95 % CI: 1.37-2.39), and dominant model (OR = 1.82, 95 % CI: 1.39-2.37) emerged as risk factors for cerebral infarction. Besides, an increased cerebral infarction risk was observed in the heterozygote comparison (OR = 1.39, 95 % CI: 1.03-1.88) for TXA2R rs2271875 polymorphism. None of the five models showed any association between TXA2R rs4523 polymorphism and cerebral infarction risk. In conclusion, this is the first meta-analysis verifying that TXA2R rs768963 polymorphism and TXA2R rs2271875 polymorphism may be associated with the risk of cerebral infarction.
更新日期:2020-11-01